Natural Antioxidants Protect Neurons in Alzheimer’s Disease and Parkinson’s Disease
“Modern” medicine and pharmacology require an effective medical drug with a single compound for a specific disease. This seams very scientific but usually has unavoidable side effects. For example, the chemical therapy to cancer can totally damage the immunological ability of the patient leading to death early than non-treatment. On the other hand, natural antioxidant drugs not only can cure the disease but also can enhance the immunological ability of the patient leading to healthier though they usually have several compounds or a mixture. For the degenerative disease such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), natural antioxidant drugs are suitable drugs, because the pathogenesis of these diseases is complex with many targets and pathways. These effects are more evidence when the clinic trial is for long term treatment. The author reviews the studies on the protecting effects of natural antioxidants on neurons in neurodegenerative diseases, especially summarized the results about protective effect of green tea polyphenols on neurons against apoptosis of cellular and animal PD models, and of genestine and nicotine on neurons against Aβ—induced apoptosis of hippocampal neuronal and transgenic mouse AD models.
KeywordsOxidative stress Green tea polyphenols Nicotine Genistein Neurodegenerative diseases Alzheimer’s disease (AD) Parkinson’s disease (PD)
This work was supported by grants from the National Natural Science Foundation of China (29935080), 973(2006CB500706), Key Laboratory of Mental Health, Chinese Academy of Sciences, the E-Institutes of Shanghai Municipal Education Commission (Project No. E-04010). I sincerely thank professor Jiankang Liu for his suggestions and comments to this paper.
- 17.Xin W-J, Zhao B-L, Zhang J-Z (1984) Studies on the property of sulfhydryl groups binding sites on the lung normal cell and cancer cell membrane of Chinese hamster with maleimide spin labels. Sci Sin [B] 28:1008–1014Google Scholar
- 18.Hirsch EC, Faucheux B, Damier P, Mouatt-Prigent A, Agid Y (1997) Neuronal vulnerability in Parkinson’s disease. J Neural Transm 50:79–88Google Scholar
- 24.Soto-Otero R, Méndez-Álvarez E, Hermida-Ameijeiras Á, Muñoz-Patiño AM, Labandeira-Garcia JL (2000) Autoxidation and neurotoxicity of 6-hydrodopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson’s disease. J Neurochem 74:1605–1612. doi: 10.1046/j.1471-4159.2000.0741605.x PubMedCrossRefGoogle Scholar
- 46.Rezai-Zadeh K, Shytle D, Sun N, Mori T, Hou H, Jeanniton D et al (2005) Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci 25:8807–8814. doi: 10.1523/JNEUROSCI.1521-05.2005 PubMedCrossRefGoogle Scholar
- 52.Ohigashi T, Ueno M, Nonnnaka S, Nakanoma T, Furukawa Y, Deguchi N et al (2000) Tyrosin kinase inhibitors reduce bcl-2 expression and induced apoptosis in androgen-depent cells. Am J Physiol 278:C66–C72Google Scholar
- 54.Clarkson TB, Anthony MS, Williams JK, Honore EK, Cline JM (1997) The potential of soybeen phytoestrogens for postmenopausal hormone replacement therapy. Proc Soc Exp Biol Med 217:365–368Google Scholar
- 55.Lamartiniere CA, Fritz WA (1998) Genistein: chemoprevention, in vivo mechanism of action, and bioavaliability. Korea Soybean Dig 15:60–80Google Scholar
- 59.Gutierrez-Zepeda A, Santell R, Wu R, Brown M, Wu Y, Khan I et al (2005) Soy isoflavone glycitein protects against beta amyloid-induced toxicity and oxidative stress in transgenic Caenorhabditis elegans. BMC Neurosci 6(54):1–9Google Scholar
- 67.Kaiser S, Wonnacott S (1998) Nicotinic receptor modulation of neurotransmitter release. In: Arneric SP, Brioni JD (eds) Neuronal nicotinic receptors: pharmacology and therapeutic opportunities. Wiley, New York, pp 141–159Google Scholar